Cabaletta Bio Inc.
CABA | NASDAQ
$2.50
+$0.04 (+1.63%)
Sep 22, 2026, 1:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.34 | -0.97 | -13.76 | -5.11 | -2.11 | -8.67 |
PEG Ratio | 0.04 | -0.02 | 1.56 | -9.20 | -0.08 | 0.13 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2 | 0.74 | 3.94 | 2.60 | 0.83 | 2.64 |
P/FCF Ratio | -1.69 | -1.24 | -17.14 | -5.56 | -2.77 | -10.54 |
P/OCF Ratio | -1.71 | -1.27 | -17.36 | -5.85 | -2.86 | -10.79 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.24 | 0.10 | 0.02 | 0.05 | n/a | n/a |
Quick Ratio | 2.77 | 6.15 | 15.29 | 11.47 | 14.86 | 21.92 |
Current Ratio | 2.77 | 6.15 | 15.29 | 11.47 | 14.86 | 21.92 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -85.95 | -167.30 | n/a | n/a | n/a | n/a |
Return on Equity | -149.80% | -76.06% | -28.65% | -50.68% | -39.24% | -30.43% |
Return on Assets | -101.68% | -62.61% | -26.68% | -45.29% | -36.64% | -29.06% |
Return on Invested Capital | -123.78% | -72.81% | -30.95% | -49.37% | -39.26% | -30.89% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CABA